Chemotherapy of epithelial ovarian carcinoma
Bruntsch, U.; Gallmeier, W.M.
Münchener Medizinische Wochenschrift 125(44): 993-995
1983
ISSN/ISBN: 0341-3098 PMID: 6417517 Document Number: 201682
Document emailed within 1 workday
Related Documents
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454Richman, C.M.; Holt, J.A.; Lorincz, M.A.; Herbst, A.L. 1985: Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy Obstetrics and Gynecology 65(2): 257-263
Lehoczky, O.ó; Pulay, T.ás. 2003: Early results of first-line chemotherapy with paclitaxel and carboplatin in patients with epithelial ovarian carcinoma Orvosi Hetilap 144(28): 1381-1384
Vrscaj, M.Ursic.; Rakar, S. 2002: Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study European Journal of Gynaecological Oncology 23(5): 405-410
Feng, Z.; Wen, H.; Liao, Q. 2014: Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines Zhonghua Fu Chan Ke Za Zhi 49(10): 780-786
Fujii, K.; Okamoto, S.; Saitoh, K.; Sasaki, N.; Takano, M.; Tanaka, S.; Kudoh, K.; Kita, T.; Tode, T.; Kikuchi, Y. 2004: The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(10): 1537-1540
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Misawa, H.; Ochiai, K.; Yasuda, M.; Tanaka, T. 2004: Combination chemotherapy with docetaxel and carboplatin for epithelial ovarian cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 546-549
Satthapong, D.; Tangjitgamol, S.; Manusirivithaya, S.; Pataradool, K. 2007: Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer Journal of the Medical Association of Thailand 90(3): 411-419
Hatae, M.; Onishi, Y.; Maeda, Y.; Nakamura, T.; Maeda, T.; Wada, T. 1995: Consensus and new development in epithelial ovarian cancer chemotherapy in 1995 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(9): 1182-1189
Wu, B.Z. 1987: Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa Zhonghua Fu Chan Ke Za Zhi 22(1): 5-8; 61
Venesmaa, P. 1994: Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstetrics and Gynecology 84(1): 8-11
Kietpeerakool, C.; Tiyayon, J.; Suprasert, P.; Kanjanavanit, R.; Srisomboon, J. 2006: Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer Journal of the Medical Association of Thailand 89(11): 1805-1810
Kotz, K.W.; Schilder, R.J. 1995: High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer Seminars in Oncology 22(3): 250-262
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Zhang, P.-n.; Sun, H. 2007: Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma Zhonghua Fu Chan Ke Za Zhi 42(3): 196-200
Wang, P.H.; Yuan, C.C.; Juang, C.M.; Lai, C.R.; Yen, M.S.; Chao, H.T.; Ng, H.T. 2001: Primary epithelial ovarian carcinoma in Taiwanese women European Journal of Gynaecological Oncology 22(1): 57-60
Sorbe, B.; Frankendal, B.; Veress, B. 1982: Importance of histologic grading in the prognosis of epithelial ovarian carcinoma Obstetrics and Gynecology 59(5): 576-582
Wen, H.; Sun, W.; Guo, Y. 1997: The clinical and pathological characteristics of epithelial ovarian carcinoma in patients with age under 40 Zhonghua Fu Chan Ke Za Zhi 32(9): 548-551
Lili, X.; Xiaoyu, T. 2015: Expression of PKCα, PKCε, and P-gp in epithelial ovarian carcinoma and the clinical significance European Journal of Gynaecological Oncology 36(2): 181-185